©DANIEL ROUSSELOT/Sanofi

Sanofi and GSK will Provide up to 300 Million doses of COVID-19 vaccine to the European Union

Originally published on sanofi.com.

Sanofi and GSK will provide up to 300 million doses of COVID-19 vaccine to the European Union

  • Agreement signed today supports scale-up of manufacturing capabilities in several European countries
  • Vaccine candidate uses Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant system

Sanofi and GSK finalized and signed today an Advanced purchase agreement with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19 vaccine, once the vaccine is approved. The vaccine candidate is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK’s established adjuvant technology. This final agreement confirms the announcement made on July 31 by both companies and marks a key milestone in protecting European populations against COVID-19.

The contract will allow the purchase of a vaccine against COVID-19 for all Member States of the European Union (EU), which may donate reserved doses to lower- and middle-income countries. The EU will provide upfront funding to support the scale-up of Sanofi and GSK manufacturing capabilities on European soil. The antigen and final vaccine doses will be manufactured in European countries, leveraging Sanofi and GSK’s industrial sites in Belgium, Italy, Germany and France.

The Companies announced the launch of its Phase 1/2 clinical study in support of the vaccine’s development on September 3rd. A Phase 3 study is planned to begin by the end of 2020 and regulatory approval could be requested in the first half of 2021. Thanks in part to the agreement signed today, Sanofi and GSK are scaling up manufacturing of the antigen and adjuvant with the intent to produce up to one billion doses per year overall to help meet high and urgent demand for vaccines worldwide.

Sanofi and GSK are working worldwide in the fight against COVID-19

Elsewhere, Sanofi and GSK recently signed agreements with the United States where they have longstanding partnerships with the Biomedical Advanced Research and Development Authority, and also with the UK Government. The partners  plan to provide a significant portion of total worldwide available supply capacity to the global initiative “Access to COVID‐19 Tools (ACT) Accelerator,” a global collaboration of leaders of governments, global health organizations, businesses and philanthropies to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.

On the front lines in the fight against COVID-19

In addition to the recombinant protein-based vaccine in collaboration with GSK, Sanofi is developing a messenger RNA (mRNA) vaccine in partnership with Translate Bio. With several innovative vaccine platforms currently being investigated across the industry, mRNA is considered among the most promising. Preclinical data have shown that two immunizations of the mRNA vaccine induced high neutralizing antibody levels that are comparable to the upper range of those observed in infected humans. Sanofi expects the Phase 1/2 study to start in November, with earliest potential approval in the second half of 2021. Translate Bio has established mRNA vaccine manufacturing capacity and Sanofi expects to be able to supply annual capacity of 90 to 360 million doses.

Latest News

San Francisco's Golden Gate Bridge

San Francisco Declares War on Racism; People 55 and Older Face Historic Levels of Unemployment; and More.

San Francisco begins a citywide war on racism and discrimination. Known as the birthplace of the “Summer of Love” and the counterculture movement of the 1960s, San Francisco has long stood as a bastion of individuality and inclusion. And now the city is continuing that fight with the launch of…

portrait of Abraham Lincoln

Was Abraham Lincoln a Racist?

Former Vice President Joe Biden’s mention of Abraham Lincoln’s name during the third presidential debate on Thursday, Oct. 22, was one of the most memorable exchanges in the final presidential debate of 2020. It also caused Lincoln to become a trending topic over much of social media in the hours…

AOC celebrates a victory in Among Us during her Twitch stream

AOC Livestreamed ‘Among Us’ on Twitch to Encourage Everyone (but Particularly Young People) to Vote

New York congresswoman Alexandria Ocasio-Cortez (AOC) is stepping up Democratic efforts to make sure young voters are prepared when heading to the polls on Election Day, especially in light of COVID-19. On Oct. 21, 2020, AOC livestreamed on Twitch to engage with the younger demographic that frequents the video game-centric…

Black Lives Matter face mask for preventing spread of COVID-19

BLM T-shirts and Trump Masks Cause Uproar at Early Polling Locations; New Credit Cards Allow Trans Individuals to Use Preferred Name; and More

BLM T-shirts and Trump masks cause uproar at early polling locations. Voters’ choice of clothing when heading to the polls in Florida and Tennessee has begun making headlines across the country. The Washington Post reported that Miami police officer Daniel Ubeda has come under fire for wearing a Trump-endorsing face…

Close-up image of COVID-19 virus

Black and Latinx Individuals Increasingly Worried About Impact of COVID-19 on Career; Potential Spike in New Disabilities Due to Pandemic; and More

More than 50% of Blacks and Latinx individuals significantly worried about finances and career prospects due to pandemic. COVID-19 continues to be top of mind for most of the country, especially as cases appear to be worsening in our current third wave of the illness. But a new survey of…

Rep. Jahana Hayes (D-Conn.)

Rep. Jahana Hayes Attacked in Racist Campaign Town Hall; 1 in 4 Americans Unemployed According to New Data from Axios; and More

Racist trolls interrupt Zoom town hall hosted by Jahana Hayes, Connecticut’s first Black congresswoman. “I am not OK,” wrote Rep. Jahana Hayes (D-Conn.) in a moving post describing a violent attack that took place at one of her recent campaign events. Ten minutes into the Zoom town hall for one…